Rumi Scientific Email Format
Biotechnology ResearchNew York, United States11-50 Employees
Rumi Scientific is a biotechnology research company based in New York, focused on discovering drugs and therapies for human genetic diseases that affect the central nervous system. It has built an organoid-based platform intended for agnostic drug discovery and adaptable to high-throughput screening. The platform uses embryonic stem cells to model human development in vitro, combining engineered disease models with multi-cellular self-organization to create defined embryonic tissues for screening. The firm operates with a small to mid-sized team. Its programmatic focus includes Huntington's Disease, with an ongoing expansion into neurodevelopmental disorders. In April 2023, it announced work on a brain-penetrant BRD9 inhibitor, identified as a notable recent development.